Bio Impact Capital LLC Akero Therapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $611 Million
- Q1 2024
A detailed history of Bio Impact Capital LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 332,924 shares of AKRO stock, worth $7.3 Million. This represents 1.38% of its overall portfolio holdings.
Number of Shares
332,924Holding current value
$7.3 Million% of portfolio
1.38%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
193Shares Held
74.2MCall Options Held
429KPut Options Held
591K-
Janus Henderson Group PLC London, X06.12MShares$134 Million0.09% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$119 Million2.2% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$115 Million3.09% of portfolio
-
Wellington Management Group LLP Boston, MA5.21MShares$114 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.89MShares$107 Million0.0% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.02B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...